Inhibikase Therapeutics Inc (IKT) short volume · $215.2M cap
Inhibikase Therapeutics Inc FINRA short-volume cache. Latest 2026-08-18.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-08-18 | 26,579 | 93,839 | 28.3% |
| 2026-08-17 | 99,620 | 201,524 | 49.4% |
| 2026-08-14 | 30,853 | 54,784 | 56.3% |
| 2026-08-13 | 54,165 | 160,343 | 33.8% |
| 2026-08-12 | 42,583 | 81,504 | 52.2% |
| 2026-08-11 | 123,977 | 309,195 | 40.1% |
| 2026-08-10 | 94,865 | 171,060 | 55.5% |
| 2026-08-07 | 107,732 | 190,404 | 56.6% |
| 2026-08-06 | 89,009 | 149,275 | 59.6% |
| 2026-08-05 | 265,510 | 426,333 | 62.3% |
FAQ
What is IKT P/E and revenue?
Inhibikase Therapeutics Inc (IKT) $215.2M cap.
What is IKT short volume?
Inhibikase Therapeutics Inc last cached short volume is 28.3% of total volume on 2026-08-18.
Not investment advice. Cached rows, not a live tape.